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Dear Editor,
Hepatitis B is one of the most prevalent infectious dis-
eases in the world, with more than two billion people 
infected  and  more  than  350  million  chronic  carriers 
(1-4).  Approximately  five  hundred  thousand  infected 
patients die annually (5). Health care workers are also at 
high risk of contracting Hepatitis B virus (HBV) through 
blood, and infected staff can transfer HBV to uninfected 
patients, which can further spread the infection into so-
ciety (6). In addition to standard precautions, personnel 
who are sensitive and susceptible or infected should be 
identified and immunized to reduce the morbidity of 
health care workers (7). Health care workers, particularly 
those working in emergency departments, are consid-
ered to be a high-risk group (8, 9). We conducted this de-
scriptive, cross–sectional study to determine the HBV an-
tibody titer and immunity levels of health care workers 
and 173 personnel working in an emergency department. 
We evaluated subjects’ HBS antibody titer with an ELISA 
method. Titer < 10 IU/L, titer ≥ 10 to 100 IU/L, and titer > 
100 IU/L were considered to be inappropriate, protective, 
and  good  levels  of  immunity,  respectively.  With  these 
cutoffs, 31 (17.19%), 72 (61.41%), and 60 (68.34%) of subjects 
had inadequate, protective, and good antibody titer lev-
els, respectively.
Additionally, 84.97% of all subjects had been complete-
ly vaccinated against Hepatitis B, and 14 (91.83%) were not 
immunized against Hepatitis B. The patients in this latter 
group (the nonimmunized group) were statistically sim-
ilar to patients with incomplete vaccinations in terms 
of  antibody  titer  level  (P  <  0.002).This  measurements 
were 81%, 88.1%, and 35% in Goldberg et al., Room et al., and 
Barash’s studies, respectively (10-12), and the figures in 
other studies in Iran were 86.4% and 96.3% in Khosravi et 
al. in Fars Province and Allami et al. in Qazvine, respec-
tively (13, 14). Our results showed a significant relation-
ship between age and hepatitis B antibody level similar 
to the level noted in Bonanni et al. in Italy. Our finding is Hepat Mon. 2011;11(8):662-663
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not consistent with Shein et al.’s finding in an American 
sample or the level found in Fonderberg et al. (6, 15, 16). It 
seems that the immune response in adults is reduced as 
a result of conditions induced from changes dependent 
on age, such as inadequate supplies of blood, malnutri-
tion,  drugs,  and  metabolic  changes  (17).  Our  research 
shows that smoking reduces the immune response to 
the hepatitis B vaccine. We also found that smoking was 
one  of  the  significant  factors  associated  with  vaccina-
tion failure response. This finding is similar to the find-
ings by Tolosa et al. in a Spanish sample and Adverhoff 
et al. but is inconsistent with Barash et al.’s finding in 
an American sample (12, 18, 19). Because antibody levels 
in the complete vaccination group were higher than in 
the incomplete vaccination group, hospital authorities 
should screen incomplete vaccination cases and encour-
age them to complete the vaccination series and assess 
ways to promote immunity levels in high-risk groups. 
Although most resources have suggested that the pro-
duction of immune antibody titer after all three HBV vac-
cination is about 95% (7), one month after the last injec-
tion, immunity status should be evaluated. In previous 
studies, repeating all three vaccinations in subjects with 
an inappropriate response induced immune induction 
in about 50% of cases (12, 14).Vaccination against hepati-
tis B in health care workers, especially in those with titers 
fewer than 10 IU/L, is essential. Furthermore, assessing 
patients> immunological response to vaccines is needed 
in the years after vaccination, and continued vaccination 
against HBV by way of an extensive immunization pro-
gram is the best way to control HBV infection.
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